UBS Group
JUNS

UBS Group’s Jupiter Neurosciences JUNS Stock Holding History

UBS Group’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52
Closed -$1.48K – 11312
2026
Q1 		$1.48K Buy
+52
New +$2.4K ﹤0.01% 9524
2025
Q4 		– Sell
-55
Closed -$7.2K – 11408
2025
Q3 		$7.2K Sell
55
-664
-92% -$75.5K ﹤0.01% 8738
2025
Q2 		$55K Sell
719
-1,090
-60% -$62.3K ﹤0.01% 7699
2025
Q1 		$82.7K Buy
+1,809
New +$294K ﹤0.01% 7196
2024
Q4 		– Hold
0
– – – 9543

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.59B AUM 51.04% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group's JUNS Position: Q2 2026 in Review

UBS Group sold out of Jupiter Neurosciences (JUNS) in Q2 2026, closing a stake of 52 shares — an estimated $1.48K sold.

UBS Group first reported a position in JUNS in Q1 2025 and held it in 4 quarters. The position peaked at $82.7K in Q1 2025. 13 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • UBS Group reported no remaining Jupiter Neurosciences position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 52 Jupiter Neurosciences shares in Q2 2026, an estimated $1.48K.
  • UBS Group first reported a position in Jupiter Neurosciences in Q1 2025 and held it in 4 quarters.
  • UBS Group's Jupiter Neurosciences position peaked at $82.7K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.